Publicaciones (79) Publicaciones en las que ha participado algún/a investigador/a

2020

  1. #NoSinMisPrácticas

    Revista Española de Educación Médica, Vol. 1, Núm. 2, pp. 65-67

  2. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

    Annals of Oncology, Vol. 31, Núm. 12, pp. 1623-1649

  3. A Systematic Literature Review of Peripheral Nerve Stimulation Therapies for the Treatment of Pain

    Pain Medicine (United States), Vol. 21, Núm. 8, pp. 1590-1603

  4. A cost-consequence analysis examining the differences between non-rechargeable and rechargeable systems

    Anesthesiology and Pain Medicine, Vol. 10, Núm. 1

  5. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

    The Lancet Oncology, Vol. 21, Núm. 11, pp. 1455-1464

  6. A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428

  7. ASCO 2020

    Breast Care

  8. Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR1, HER22, node-positive, high-risk, early breast cancer (monarchE)

    Journal of Clinical Oncology, Vol. 38, Núm. 34, pp. 3987-3998

  9. Aplicación de un calendario de pruebas de evaluación continua en la asignatura “Obstetricia” en sexto de Medicina

    Revista Española de Educación Médica, Vol. 1, Núm. 2, pp. 45-52

  10. Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients with Cancer

    JAMA Dermatology, Vol. 156, Núm. 9, pp. 963-972

  11. Association of pathologic complete response with long-term survival outcomes in triple-negative breast cancer: A meta-analysis

    Cancer Research, Vol. 80, Núm. 24, pp. 5427-5434

  12. Atezolizumab in the treatment of metastatic triple-negative breast cancer

    Expert Opinion on Biological Therapy, Vol. 20, Núm. 9, pp. 981-989

  13. Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial

    Open Heart, Vol. 7, Núm. 2

  14. Calcified plaques in the radial artery: OCT insight

    REC: Interventional Cardiology

  15. Can we cure oligometastatic disease? A practical point of view

    Current opinion in oncology, Vol. 32, Núm. 6, pp. 568-574

  16. Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: The PAKT trial

    Journal of Clinical Oncology

  17. Cdk4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Current practice and knowledge

    Cancers, Vol. 12, Núm. 9, pp. 1-19

  18. Clinical use of 4D flow MRI for quantification of aortic regurgitation

    Open Heart, Vol. 7, Núm. 1

  19. Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

    Frontiers in Oncology, Vol. 10

  20. Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients

    Cancer Treatment Reviews, Vol. 83